133 related articles for article (PubMed ID: 37461352)
21. [Paediatric training for developing clinical activities].
Echarri-Martínez L; Fernández-Llamazares CM; López-Herce J; Sánchez-Galindo A; Manrique-Rodríguez S; Sanjurjo-Sáez M
Farm Hosp; 2012; 36(1):43-9. PubMed ID: 22030160
[TBL] [Abstract][Full Text] [Related]
22. Pharmacy program for improved handling of antineoplastic agents.
Scott SA; Schrott DB; Loesch GA
Am J Hosp Pharm; 1983 Jul; 40(7):1179-82. PubMed ID: 6881156
[TBL] [Abstract][Full Text] [Related]
23. Current challenges in European oncology pharmacy practice.
Hoppe-Tichy T
J Oncol Pharm Pract; 2010 Mar; 16(1):9-18. PubMed ID: 20015932
[TBL] [Abstract][Full Text] [Related]
24. Current state assessment survey of challenges of pharmacogenomics within oncology pharmacy practice.
Przybylski DJ; Dow-Hillgartner EN; Reed MP; Fallon MJ
J Oncol Pharm Pract; 2020 Sep; 26(6):1374-1381. PubMed ID: 31937189
[TBL] [Abstract][Full Text] [Related]
25. Critical Care Network in the State of Qatar.
Hijjeh M; Al Shaikh L; Alinier G; Selwood D; Malmstrom F; Hassan IF
Qatar Med J; 2019; 2019(2):2. PubMed ID: 31763205
[TBL] [Abstract][Full Text] [Related]
26. Documentation of chemotherapy infusion preparation costs in academic- and community-based oncology practices.
Brixner DI; Oderda GM; Nickman NA; Beveridge R; Jorgenson JA
J Natl Compr Canc Netw; 2006 Mar; 4(3):197-208. PubMed ID: 16507268
[TBL] [Abstract][Full Text] [Related]
27. Pediatric oncology services in Nepal: A special focus on pharmacy practice.
Dhungana S; Pathak N; Basyal B; Sah AK; Pandit A; Kunwor P; Karki R
J Oncol Pharm Pract; 2024 Mar; 30(2):425-435. PubMed ID: 38321882
[TBL] [Abstract][Full Text] [Related]
28. Improving Care for Children With Cancer in Low- and Middle-Income Countries--a SIOP PODC Initiative.
Arora RS; Challinor JM; Howard SC; Israels T
Pediatr Blood Cancer; 2016 Mar; 63(3):387-91. PubMed ID: 26797891
[TBL] [Abstract][Full Text] [Related]
29. Development and implementation of an interdisciplinary oncology program in a community hospital.
Chung C; Collins A; Cui N
Am J Health Syst Pharm; 2011 Sep; 68(18):1740-7. PubMed ID: 21880891
[TBL] [Abstract][Full Text] [Related]
30. Targeting Financial Toxicity in Oncology Specialty Pharmacy at a Large Tertiary Academic Medical Center.
Farano JL; Kandah HM
J Manag Care Spec Pharm; 2019 Jul; 25(7):765-769. PubMed ID: 31232209
[TBL] [Abstract][Full Text] [Related]
31. Pharmacy staff interventions in a medical center hematology-oncology service.
Waddell JA; Solimando DA; Strickland WR; Smith BD; Wray MK
J Am Pharm Assoc (Wash); 1998; 38(4):451-6. PubMed ID: 9707955
[TBL] [Abstract][Full Text] [Related]
32. 25 years of safe handling of cytotoxics (antineoplastics) in Israel.
Cass Y; Setton I
J Oncol Pharm Pract; 2006 Jun; 12(2):83-90. PubMed ID: 16984746
[TBL] [Abstract][Full Text] [Related]
33. Pharmacists' roles in oncology pharmacy services: Results of a global survey.
Holle LM; Harris CS; Chan A; Fahrenbruch RJ; Labdi BA; Mohs JE; Norris LB; Perkins J; Vela CM
J Oncol Pharm Pract; 2017 Apr; 23(3):185-194. PubMed ID: 26854267
[TBL] [Abstract][Full Text] [Related]
34. Training pediatric hematologist/oncologists for capacity building in Ethiopia.
Hailu D; Fufu Hordofa D; Adam Endalew H; Karimi Mutua D; Bekele W; Bonilla M; Çeliker MY; Challinor J; Dotan A; Habashy C; Kumar PN; Rodriguez-Galindo C; Wali RM; Weitzman S; Broas J; Korones DN; Alexander TB; Shad AT
Pediatr Blood Cancer; 2020 Dec; 67(12):e28760. PubMed ID: 33049116
[TBL] [Abstract][Full Text] [Related]
35. The Practice of Paediatric Radiation Oncology in Low- and Middle-income Countries: Outcomes of an International Atomic Energy Agency Study.
Anacak Y; Zubizarreta E; Zaghloul M; Laskar S; Alert J; Gondhowiardjo S; Giselvania A; Correa-Villar R; Pedrosa F; Dorj B; Kamer S; Howard SC; Quintana Y; Ribeiro RC; Rosenblatt E; Hopkins K
Clin Oncol (R Coll Radiol); 2021 Apr; 33(4):e211-e220. PubMed ID: 33250288
[TBL] [Abstract][Full Text] [Related]
36. International Society of Oncology Pharmacy Practitioners (ISOPP) position statement: Role of the oncology pharmacy team in cancer care.
Holle LM; Bilse T; Alabelewe RM; Kintzel PE; Kandemir EA; Tan CJ; Weru I; Chambers CR; Dobish R; Handel E; Tewthanom K; Saeteaw M; Dewi LKM; Schwartz R; Bernhardt B; Garg M; Chatterjee A; Manyau P; Chan A; Bayraktar-Ekincioglu A; Aras-Atik E; Harvey RD; Goldspiel BR
J Oncol Pharm Pract; 2021 Jun; 27(4):785-801. PubMed ID: 34024179
[TBL] [Abstract][Full Text] [Related]
37. Integration of a clinical pharmacist into the hematology-oncology clinics at an academic medical center.
Valgus JM; Faso A; Gregory KM; Jarr S; Savage S; Caiola S; Walko CM; Kim J; Bernard SA
Am J Health Syst Pharm; 2011 Apr; 68(7):613-9. PubMed ID: 21411803
[TBL] [Abstract][Full Text] [Related]
38. Infection Prevention and Control Measures at the Children Hospital Lahore: A My Child Matters Collaborative Project.
Faizan M; Caniza MA; Anwar S; Kashif RU; Saleem R; Javed H; Zafar A; Taj MM; Hameed A; Homsi M; Rathore AW; Sadiq M; Gonzalez M; Zaidi A
JCO Glob Oncol; 2020 Oct; 6():1540-1545. PubMed ID: 33064627
[TBL] [Abstract][Full Text] [Related]
39. Credentialing and privileging of pharmacists: a resource paper from the Council on Credentialing in Pharmacy.
Council on Credentialing in Pharmacy
J Am Pharm Assoc (2003); 2014; 54(6):e354-64. PubMed ID: 25257963
[TBL] [Abstract][Full Text] [Related]
40. 2018 Hematology/Oncology Pharmacist Association Best Practices for the Management of Oral Oncolytic Therapy: Pharmacy Practice Standard.
Mackler E; Segal EM; Muluneh B; Jeffers K; Carmichael J
J Oncol Pract; 2019 Apr; 15(4):e346-e355. PubMed ID: 30860937
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
